Clario and Sleepiz AG bring innovative sleep and respiratory data collection features to clinical trials followup

Clario’s customer-driven Sleepiz device integration paves the way for novel data endpoints through patient-centric and unobtrusive monitoring with a focus on accurate and longitudinal data points.

• Through Clario’s device integration support, Sleepiz’s contactless sleep and respiratory measurements facilitate in-depth health insights in previously subjective and burdensome areas for a clinical trial.
• Sleepiz AG’s cutting-edge sleep and respiration measurement device enables accurate, comfortable and natural data collection through a patient-centric and unobtrusive radar technology.
• This collaboration exemplifies Clario’s customer-focused approach to partnerships, using a strategic focus and expertise to deliver a unique solution.

PHILADELPHIA, PA – July 17, 2023 –Clario, a healthcare research technology company that delivers leading endpoint technology solutions for clinical trials, and the medical technology company Sleepiz AG announced a sponsor-driven partnership to integrate novel sleep and respiratory parameters into clinical trials. Sleepiz’s device integration paves the way for new data endpoints through patient-centric and unobtrusive monitoring with a focus on accurate and longitudinal data points.

Leveraging Sleepiz’s cutting-edge technology, Clario offers continuous assessment of sleep and respiratory parameters in a continuous and natural environment. This device integration, for implementing in a clinical trial, can provide additional endpoints, contributing to a more comprehensive and detailed understanding of patients’ sleep and respiratory conditions.

“Clario’s partnership with Sleepiz exemplifies its dedication to providing a customer-focused and flexible approach that supports their unique clinical trial needs,” said Terry Burke, Executive Vice President, Electronic Clinical Outcome Assessments (eCOA), Clario.

About Sleepiz 

Sleepiz AG (Ltd.) is a Zurich, Switzerland-based medical technology company with a mission to provide patient-centric disease management through seamless integration of contactless monitoring into people’s homes. Sleepiz leverages the power of sleep insights with a device that is simply placed on the bedside table. The device operates in a contactless fashion and measures movements originating from heart contractions and breathing patterns, as well as body motions, with medical-grade accuracy. While focusing on respiratory illnesses as a first step, Sleepiz aims to improve people’s lives by creating the future of healthcare. By making use of wireless millimeter wave technology, sensor fusion, and artificial intelligence, Sleepiz enables the diagnosis of sleep disorders as well as the monitoring of the progression of chronic diseases for faster intervention and better treatment. 

More information at www.sleepiz.com.